Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia; Kidney Health Service, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia; Faculty of Medicine and Institute for Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.
Kidney Int. 2022 Jan;101(1):23-35. doi: 10.1016/j.kint.2021.09.024. Epub 2021 Nov 1.
Registries are essential for health infrastructure planning, benchmarking, continuous quality improvement, hypothesis generation, and real-world trials. To date, data from these registries have predominantly been analyzed in isolated "silos," hampering efforts to analyze "big data" at the international level, an approach that provides wide-ranging benefits, including enhanced statistical power, an ability to conduct international comparisons, and greater capacity to study rare diseases. This review serves as a valuable resource to clinicians, researchers, and policymakers, by comprehensively describing kidney failure registries active in 2021, before proposing approaches for inter-registry research under current conditions, as well as solutions to enhance global capacity for data collaboration. We identified 79 kidney-failure registries spanning 77 countries worldwide. International Society of Nephrology exemplar initiatives, including the Global Kidney Health Atlas and Sharing Expertise to support the set-up of Renal Registries (SharE-RR), continue to raise awareness regarding international healthcare disparities and support the development of universal kidney-disease registries. Current barriers to inter-registry collaboration include underrepresentation of lower-income countries, poor syntactic and semantic interoperability, absence of clear consensus guidelines for healthcare data sharing, and limited researcher incentives. This review represents a call to action for international stakeholders to enact systemic change that will harmonize the current fragmented approaches to kidney-failure registry data collection and research.
登记处对于卫生基础设施规划、基准测试、持续质量改进、假设生成和真实世界试验至关重要。迄今为止,这些登记处的数据主要在孤立的“筒仓”中进行分析,这阻碍了在国际层面分析“大数据”的努力,这种方法提供了广泛的益处,包括增强统计能力、进行国际比较的能力以及研究罕见疾病的更大能力。本综述为临床医生、研究人员和政策制定者提供了有价值的资源,全面描述了 2021 年活跃的肾脏衰竭登记处,并在当前条件下提出了进行登记处间研究的方法,以及增强全球数据协作能力的解决方案。我们确定了全球 77 个国家/地区的 79 个肾脏衰竭登记处。国际肾脏病学会的范例举措,包括全球肾脏健康图谱和共享专业知识以支持肾脏登记处的建立(SharE-RR),继续提高对国际医疗保健差距的认识,并支持建立通用的肾脏疾病登记处。登记处间协作的当前障碍包括低收入国家代表性不足、语法和语义互操作性差、缺乏明确的医疗保健数据共享共识指南以及研究人员激励措施有限。本综述呼吁国际利益相关者采取系统性变革,协调当前肾脏衰竭登记处数据收集和研究的零散方法。